Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/30/2008WO2008128995A1 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008WO2008128994A1 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008WO2008128987A1 Novel inhibitors
10/30/2008WO2008128986A1 Urea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128985A1 Thiourea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128984A1 Aminopyrimidine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128983A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128982A1 Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128981A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128919A2 Histamine h3 receptor ligands comprising a cyclobutoxy group
10/30/2008WO2008128891A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008WO2008128889A1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
10/30/2008WO2008128740A1 Titration of tapentadol
10/30/2008WO2008128739A1 Tapentadol for treating pain from arthritis
10/30/2008WO2008128436A1 Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof
10/30/2008WO2008128431A1 L-stepholidine (l-spd) derivatives, preparation method and usage thereof
10/30/2008WO2008128316A1 A ginkgo biloba and ginseng composition for the improvement of memory function, cognitive function, and mental health
10/30/2008WO2008128280A1 Method and system for transdermal administration of volatile active
10/30/2008WO2008107677A3 Thiadiazole and oxadiazole derivatives for the treatment of neurodegenerative disorders
10/30/2008WO2008103185A3 Substituted carboxamides as group i metabotropic receptor antagonists
10/30/2008WO2008088900A3 Polymorphic forms of rimonabant base and processes for preparation thereof
10/30/2008WO2008087461B1 Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis
10/30/2008WO2008087323A3 Galenic form for the transmucosal delivery of paracetamol
10/30/2008WO2008074329A3 Modulation of activity of proneurotrophins
10/30/2008WO2008069921A3 Oral transmucosal nicotine dosage form
10/30/2008WO2008067177A3 Methods for the treatment of alcohol abuse, addiction and dependency
10/30/2008WO2008056377A3 Polymorphic forms of rimonabant
10/30/2008WO2008036678A3 Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
10/30/2008WO2008005471A3 Novel heterobicyclic compounds
10/30/2008WO2007126362A8 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
10/30/2008WO2007106439A3 Homotropanes with central nervous system activity
10/30/2008US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes
10/30/2008US20080269348 Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080269327 Magnesium threonate, useful for administration to a subject presenting magnesium deficiency, mild cognitive impairment, Alzheimer's disease, attention deficit hyperactivity disorder, ALS, Parkinson's disease, diabetes, migraine, anxiety disorder,hypertension
10/30/2008US20080269326 1-dimethylamino-3-(3-methoxyphenyl)-2methyl-pentan-3-ol; 3-(3-dimethylamino-1-hydroxy-1,2-dimethylpropyl)-phenol; treating diabetic peripheral neuropathy
10/30/2008US20080269323 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphthyl)-propanoate for treating pain and inflammation
10/30/2008US20080269321 Therapeutic Combinations for the Treatment or Prevention of Depression
10/30/2008US20080269316 Pharmaceutical Compositions Comprising Levetiracetam and Process for Their Preparation
10/30/2008US20080269313 Prolyl Oligopeptidase Inhibitors Ameliorating Recovery From Brain Trauma
10/30/2008US20080269306 Antidepressant Medicament Comprising Idazoxan and a Selective Serotonin Reuptake Inhibitor
10/30/2008US20080269303 Diaryloxazole carboxamide derivatives for treating a disease selected from appetite disorder, metabolic disorder, gastrointestinal disorder, inflammatory phenomena, immune system disease, psychotic disorder, alcohol dependency and nicotine dependency
10/30/2008US20080269302 Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269290 Indoles
10/30/2008US20080269287 Substituted Pyridone Derivative
10/30/2008US20080269286 Disubstituted Phenylpiperidines as Modulators of Cortical Catecholaminergic Neurotransmission
10/30/2008US20080269279 Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulators
10/30/2008US20080269271 Analgesics; antidepressants; neurodegenerative diseases; antiepileptic agents; cognition activators; antitussive agents; incotinence; irritable bowel syndrome; stroke; vision defects; antiinflammatory agents; skin disorders; diarrhea; eating disorders
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269257 Use of Substituted 2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A] Pyrimidin-4-one and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-A] Pyrimidin-5(1H)one Derivatives
10/30/2008US20080269256 Central nervous system disorders; antidepressants;anxiolytic agents; psychological disorders; antiepileptic agents; schizophrenia; Alzheimer's disease; antiischemic agents; antiepileptic agents
10/30/2008US20080269253 Pain therapy; headaches; neurodegenerative diseases; stroke; skin disorders; antiischemic agents; Huntington's disease; antiulcer agents; inflammatory bowel disorders;amyotropic lateral sclerosis
10/30/2008US20080269252 Use of Compounds Derived From Pyrimidinetrione as Acetyl Cholinesterase Inhibitors, Compositions Containing Said Derivatives, and the Uses Thereof
10/30/2008US20080269251 Central nervous system disorders; psychological disorders; anxiolytic agents; antidepressants; Parkinson's disease; Alzheimer's disease; analgesics; neurodegenerative diseases; sexual disorders
10/30/2008US20080269248 Tartrate and Malate Salts of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine
10/30/2008US20080269246 Cognition activators; psychological disorders; autism; mental retardation; obessive compulsive disorders ; administering ziprasidone
10/30/2008US20080269242 Central nervous system disorders in mammals; antidepressants; bipolar disorders; schizophrenia; autism; attention deficit disorders; post-traumatic stress disorders
10/30/2008US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group
10/30/2008US20080269236 Novel 1,2,4 Oxadiazole Compounds and Methods of Use Thereof
10/30/2008US20080269230 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
10/30/2008US20080269229 Serotonine, dopamine and norendrenaline receptors; antidepressants, anxiolytic agents, eating disorders; obesity; bipolar; drug abuse; neurodegenerative diseases
10/30/2008US20080269227 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
10/30/2008US20080269219 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
10/30/2008US20080269211 Antiserotonine agents; gastrointestinal disorders; irritable bowel syndrome; central nervous system disorders; Alzheimer's disease; cognition activators; analgesics; cardiovascular disorders; antidiabetic agents; sleep disorders
10/30/2008US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
10/30/2008US20080269204 Benzolactam boronic acid compounds; blocking inflammatory cytokines and tumor necrosis ; phosphodiesterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders
10/30/2008US20080269202 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
10/30/2008US20080269201 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents
10/30/2008US20080269199 Therapy for obesity, diabetes, sleep disorders, Alzheimer's disease, Parkinson's disease; attention deficit disorders; antiepileptic agents; schizophrenia; antidepressants; anxiolytic agents
10/30/2008US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
10/30/2008US20080269195 Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine
10/30/2008US20080269184 Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
10/30/2008US20080269183 Adjust permeability of bain-blood barrier; multiple sclerosis; Alzheimer's disease; Parkinson's disease; spinal cord injuries; antiischemic agents; stroke; adjust cholesterol metabolism; cardiovascular disorders
10/30/2008US20080269176 New Salts
10/30/2008US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
10/30/2008US20080269154 Mesencephalic astrocyte-derived neurotrophic factor; peripheral neuropathy; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269149 Adeno-associated virus (AAV); genetic engineering; parvoviruses; gene therapy; muscle delivery; glioblastoma; Parkinson's Disease
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269120 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
10/30/2008US20080269110 Non-basic melanin concentrating hormone receptor-1 antagonists
10/30/2008US20080269103 Diagnostic and Therapeutic Use of the Kcne4 Gene and Protein for Alzheimer's Disease
10/30/2008US20080268489 Therapeutic polypeptide for use in treatment of heart, hypothermic and cardiovascular disorders
10/30/2008US20080268071 NMDA receptor modulators
10/30/2008US20080268067 inhibiting a Cav3 calcium channel in a cell using a C2-C10 alkyl alcohol;
10/30/2008US20080268065 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm
10/30/2008US20080268042 Omega 3 fatty acid formulations
10/30/2008US20080268034 High surface area of colloidal silicon dioxide neutralizes the surface charges from the particles which then de-segregate into individual particles, with colloidal silicon dioxide acting as a drug carrier; easily processed into a desired dosage form
10/30/2008US20080268027 Oral administering a drug; drying self-supporting polymer film and drug dosage
10/30/2008US20080267986 Using beta amyloid antigenic fragment to produce vaccine for prevention and treatment of autoimmune, nervous system and diabetic disorders
10/30/2008US20080267983 Mimetic peptide for use in treatment and prevention of stroke, cardiovascular, neurodegenerative, inflammatory and vision defects
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267952 Using concentration of immunoglobulins specific oxidized forms of amyloid beta in blood as evalauative indicator of alzheimer's disease
10/30/2008US20080267934 Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
10/30/2008US20080267912 Novel inhibitors of glutaminyl cyclase
10/30/2008US20080267911 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/30/2008US20080267870 1-[(2'-Substituted)-piperazin-1' -yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents
1 ... 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 ... 1833